We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current DRMA market cap is 1.08M. The company's latest EPS is USD -17.5541 and P/E is -0.15.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.28M | -1.73M | -1.81M | -2.22M | -3.2M |
| Net Income | -2.24M | -1.7M | -1.72M | -2.13M | -3.13M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -3.17M | -7.86M | -9.67M | -8.04M |
| Net Income | -3.24M | -7.9M | -9.61M | -7.8M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Assets | 9.3M | 8.71M | 7.32M | 7.98M | 5.18M |
| Total Liabilities | 1.21M | 683k | 916k | 1.62M | 1.37M |
| Total Equity | 8.09M | 8.03M | 6.41M | 6.36M | 3.81M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 605k | 11.62M | 6.94M | 7.98M |
| Total Liabilities | 3.78M | 1.52M | 922k | 1.62M |
| Total Equity | -3.18M | 10.11M | 6.02M | 6.36M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Operating | -1.65M | -3.49M | -5.26M | -6.41M | -2.7M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 4.18M | 5.69M | 5.65M | 7.61M | N/A |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -4.03M | -5.69M | -8.83M | -6.41M |
| Investing | N/A | N/A | N/A | N/A |
| Financing | 2.57M | 15.96M | 4.28M | 7.61M |
| Market Cap | 1.08M |
| Price to Earnings Ratio | -0.15 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.15 |
| Price to Book Ratio | 0.18 |
| Dividend Yield | - |
| Shares Outstanding | 444.06k |
| Average Volume (1 week) | 266.9k |
| Average Volume (1 Month) | 122.39k |
| 52 Week Change | -90.00% |
| 52 Week High | 26.55 |
| 52 Week Low | 2.099 |
| Spread (Intraday) | 0.01 (0.41%) |
| Company Name | Dermata Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.dermatarx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
